Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
嗜酸性
表型
哮喘
医学
病理
内科学
生物
遗传学
基因
作者
David J. Jackson,Michael E. Wechsler,Daniel J. Jackson,David I. Bernstein,Stephanie Korn,Paul Pfeffer,Ruchong Chen,Junpei Saito,Gustavo de Luíz Martinez,Lucyna Dymek,Loretta Jacques,Nicholas Bird,Stein Schalkwijk,Douglas G. Smith,Peter Howarth,Ian Pavord
Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals.
PDF的下载单位、IP信息已删除
(2025-6-4)
herococa
Kuga
HEIKU
aldehyde
自信幻灵
eric888
OCDer
不瞌睡
孙燕
MchemG
YifanWang
科研01
Capybara
27小天使
无敌暴龙战神
从容芮
sissiarno
深海鱼油DHA
jianxiu
ephore
皖公网安备34019202002308
